Vert Asset Management LLC Has $5.21 Million Stock Position in Healthpeak Properties, Inc. $DOC

Vert Asset Management LLC lowered its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 8.4% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 297,762 shares of the real estate investment trust’s stock after selling 27,381 shares during the period. Healthpeak Properties makes up about 1.9% of Vert Asset Management LLC’s holdings, making the stock its 17th biggest position. Vert Asset Management LLC’s holdings in Healthpeak Properties were worth $5,214,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in DOC. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Healthpeak Properties by 584.6% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 9,218,848 shares of the real estate investment trust’s stock worth $186,405,000 after purchasing an additional 7,872,150 shares during the period. Nuveen LLC acquired a new stake in Healthpeak Properties during the first quarter worth approximately $124,113,000. Invesco Ltd. grew its stake in Healthpeak Properties by 20.7% during the first quarter. Invesco Ltd. now owns 23,111,320 shares of the real estate investment trust’s stock worth $467,311,000 after purchasing an additional 3,967,830 shares during the period. Goldman Sachs Group Inc. grew its stake in Healthpeak Properties by 57.8% during the first quarter. Goldman Sachs Group Inc. now owns 6,764,854 shares of the real estate investment trust’s stock worth $136,785,000 after purchasing an additional 2,477,307 shares during the period. Finally, Amundi grew its stake in Healthpeak Properties by 89.4% during the first quarter. Amundi now owns 5,047,699 shares of the real estate investment trust’s stock worth $98,228,000 after purchasing an additional 2,382,657 shares during the period. Institutional investors and hedge funds own 93.57% of the company’s stock.

Analysts Set New Price Targets

A number of research firms recently weighed in on DOC. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a $18.00 price target (down from $28.00) on shares of Healthpeak Properties in a research note on Wednesday, August 20th. Evercore ISI set a $22.00 price objective on Healthpeak Properties in a research note on Monday, September 15th. Wells Fargo & Company decreased their price target on Healthpeak Properties from $20.00 to $18.00 and set an “equal weight” rating for the company in a research report on Wednesday, August 27th. Scotiabank lowered Healthpeak Properties from a “sector outperform” rating to a “sector perform” rating and reduced their price objective for the company from $21.00 to $19.00 in a report on Tuesday, July 29th. Finally, Wall Street Zen lowered Healthpeak Properties from a “hold” rating to a “sell” rating in a report on Monday, July 7th. Eight analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $21.33.

Healthpeak Properties Stock Performance

Healthpeak Properties stock opened at $19.21 on Thursday. The stock’s 50 day simple moving average is $17.82 and its two-hundred day simple moving average is $18.05. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.28 and a current ratio of 1.28. The stock has a market cap of $13.35 billion, a price-to-earnings ratio of 80.02, a PEG ratio of 2.47 and a beta of 1.09. Healthpeak Properties, Inc. has a fifty-two week low of $16.63 and a fifty-two week high of $23.26.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, hitting the consensus estimate of $0.46. The company had revenue of $694.35 million for the quarter, compared to the consensus estimate of $697.14 million. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%.The firm’s quarterly revenue was down .2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.45 EPS. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. As a group, analysts expect that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.

Healthpeak Properties Dividend Announcement

The company also recently declared a monthly dividend, which was paid on Friday, August 29th. Stockholders of record on Monday, August 18th were issued a dividend of $0.1017 per share. This represents a c) annualized dividend and a dividend yield of 6.4%. The ex-dividend date of this dividend was Monday, August 18th. Healthpeak Properties’s dividend payout ratio is presently 508.33%.

Insider Buying and Selling at Healthpeak Properties

In other news, CEO Scott M. Brinker purchased 2,930 shares of the stock in a transaction dated Thursday, July 31st. The shares were purchased at an average cost of $17.06 per share, with a total value of $49,985.80. Following the acquisition, the chief executive officer directly owned 210,416 shares of the company’s stock, valued at $3,589,696.96. This represents a 1.41% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Over the last quarter, insiders acquired 8,783 shares of company stock worth $150,129. 0.23% of the stock is owned by corporate insiders.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.